Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shared insights on. Cramer discussed the company stock in ...

Dallas-based Dean Omar Branham Shirley is handling another talcum powder trial against Johnson & Johnson, which began on ...

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Johnson & Johnson (NYSE:JNJ) is ...

Johnson & Johnson faces legal pressures from talc lawsuits, likely to create persisting growth and valuation headwinds. Read why I reiterate hold rating on JNJ.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Johnson & Johnson (NYSE: JNJ) is an iconic U.S. healthcare giant. There are a lot of positives with J&J, as it is more commonly known on Wall Street, but there's one dark cloud that I can't ignore.

Johnson & Johnson moved to dismiss an amended, proposed class action alleging the company engaged in fraudulent transfers to cheat talc litigation plaintiffs of recoveries.

Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Premier Strategy” ...

"No More Tears," by Gardiner Harris, is a scathing expose of Johnson & Johnson and its many missteps and transgressions.